Comment on the actual content presented. Give suggestions to help…

Question Answered step-by-step Comment on the actual content presented. Give suggestions to help… Comment on the actual content presented. Give suggestions to help your peers improve their argumentative research paper.Wegovy demonstrated significant and sustained weight loss in two-year study in adults with obesity: – The STEP 5 trial demonstrated an average weight loss of 15.2% with Wegovy™ at 104 weeks when used with a reduced calorie meal plan and increased physical activity vs. 2.6% with placebo.  Obesity is a chronic disease associated with at least 60 other health conditions. With the new FDA-approved drug called Wegovy, it is possible to lose weight. The results of the trial showed that people treated with the Wegovy injection achieved weight loss during the two-year study, this was accompanied by a reduced-calorie eating plan and increased physical activity. Wegovy demonstrated significant and sustained weight loss in two-year. (2021, November 5). PR Newswire.  Wegovy (semaglutide): a new weight loss drug for chronic weight management.  Obesity is growing more and more in the US and is already considered a growing epidemic due to weight gain and an increasing risk of developing life-threatening diseases such as hypertension or type 2 diabetes. Glucagon-like peptide-1 (GLP) receptor agonists -1) are a class of antidiabetic drugs that have shown promise for weight loss in patients with and without type 2 diabetes. The SUSTAIN and PIONEER clinical trials studied the use of 1.0 mg, once weekly, of subcutaneous and oral semaglutide (a new GLP-1 homologue), in participants with type 2 diabetes. The STEP trial resulted in the effects semaglutide 2.4 mg subcutaneously once a week in obese patients. Trial data and other relevant articles were obtained by searching the database through the United States National Library of Clinical Trials of Medicine and the National Clearinghouse for Information All 3 clinical trials demonstrated that semaglutide (injectable or oral) has better efficacy compared to placebo and other antidiabetic drugs in reducing weight, and this led to the Food and Drug Administration approval of Wegovy (semaglutide) for weight loss. Singh, G., Krauthamer, M., & Bjalme-Evans, M. (2022, January 1). Wegovy (SEMAGLUTIDE): A new weight loss drug for Chronic Weight Management. Journal of Investigative Medicine. Retrieved June 8, 2022, from https://doi.org/10.1136/jim-2021-001952    What do you believe makes an argumentative paper strong? Explain an interesting or controversial subject the argument must have The thesis, here it must be written, the opinion that will be defended, The arguments, which support that opinion or thesis, The conclusion, which reinforces what was presented.  What do you believe makes an argument weak? when an argument has no solidity, false or inconsistent conclusions, another error is the false analogy, when the argument is false. why? because if we put false information it is no longer credible and the argument is useless. why not? because they are presented as apparent arguments but the validity is weak or null, likewise, they incur in disqualification or deception.  List three or four argumentative transitions/ transitional phrases to use to make your tone persuasive to your audience. Overall In addition However As a result after all, even so, in addition, on the other hand, for example, as a result   Arts & Humanities Writing ENC 1102 Share QuestionEmailCopy link Comments (0)